Patent GB-1220750-A (GB)
Title: New spiro-azatetramethylene derivatives
Inventor: BOCK CORNELIS ALBERTUS DE
IPC: B01L99/00
Filed: 1968-07-03
Abstract: 1,220,750. 2,2 - (2 - Azatetramethylene)- adamantane and derivatives thereof. PHILIPS' GLOEILAMPENFABRIEKEN N.V. 3 July, 1968 [6 July, 1967; 5 April, 1968], No. 31692/68. Heading C2C. Novel 2,2 - (2 - azatetramethylene) - adamantane and derivatives thereof of the general formula wherein R is a hydrogen atom, an n-alkyl group having up to 3 carbon atoms or a propargyl group, and salts thereof with pharmaceutically acceptable acids are prepared (a) when R is a hydrogen atom or an n-alkyl group having up to 3 carbon atoms, by reduction of a ketone of the general formula wherein Y and Y<SP>1</SP> are each a double-bonded oxygen atom or one of them represents two hydrogen atoms and the other is a doublebonded oxygen atom; (b) when R is an n-alkyl group having up to 3 carbon atoms or a propargyl group, by alkylation of 2,2-(2-azatetramethylene) - adamantane with a compound of one of the general formulµ RHal and R 2 SO 4 , wherein Hal is a halogen atom; (c) when R is an n-alkyl group having up to 3 carbon atoms, by reductive alkylation of 2,2-(2-azatetramethylene) - adamantane; (d) when R is an n-alkyl group having up to 3 carbon atoms, by acylation of 2,2-(2-azatetramethylene)-adamantane and reduction of the resulting N- alkanoyl - 2,2 - (2 - azatetramethylene) - adamantane; (e) when R is a propargyl group, by dehydrobromination or debromination of an N-substituted - 2,2 - (2 - azatetramethylene)- adamantane of the general formula wherein R 1  is a -CBr=CH 2  or -CHBr- CH2Br group, respectively; (f) when R is a propargyl group, by reaction of 2,2-(2-azatetramethylene)-adamantane with formaldehyde and acetylene; or (g) when R is a hydrogen atom, by subjection of 2-aminomethyl-2- (#-aminoethyl)- adamantane or an acid addition salt thereof to heat at a temperature above its melting-point; followed optionally by salification of the resulting product. Ketones of the second general formula above wherein Y and Y<SP>1</SP> are each a double-bonded oxygen atom are prepared by reaction of adamentanone with a cyanoacetic acid alkyl ester by the Cope method, treatment of the resulting adamantylidenecyanoacetic acid alkyl ester with potassium cyanide in methanol, saponification of the resulting 2-cyano-2-cyanomethyl-adamantane with concentrated sulphuric acid, followed by treatment with concentrated hydrochloric acid to produce 2,2-(2-oxa-1,3- diketotetramethylene)-adamantane, which is then reacted with ammonia or an amine of the general formula RNH 2 , wherein R is a hydrogen atom or an n-alkyl group having up to 3 carbon atoms, to give the desired ketone. 2-Aminomethyl - 2 - (# - aminoethyl) - adamantane dihydrochloride is prepared by hydrogenation of 2 - cyano - 2 - cyanomethyl - adamantane in the presence of platinum oxide and ethanolic hydrochloric acid. Pharmaceutical compositions having antiviral activity comprise, as active ingredient, 2,2 - (2 - azatetramethylene) - adamantane or a derivative thereof of the first general formula above or a salt thereof with a pharmaceutically acceptable acid, together with an inert, solid, liquid or gaseous carrier, and may be administered orally, parenterally or rectally.